COPD

News

FDA rejects Sunovion's nebulised COPD drug

The US regulator has rejected Sunovion’s nebulised therapy for chronic obstructive pulmonary disease (COPD), leaving the company struggling to stay ahead of rivals.

News

European regulators back Chiesi COPD triple therapy

Chiesi takes on Seretide and other lung drugs with Trimbow.

News

GSK’s Relvar Ellipta comes out on top in real world study

Encouraging results will support growth of its next generation respiratory treatment

News

Circassia gives up on allergy treatments after second trial ...

UK biotech to focus on respiratory drugs after house dust mite therapy fails.

News

AZ strikes COPD deal with Circassia, suffers setback with bl...

FDA rejects blood potassium drug for second time.

News

Good news for GSK’s next generation asthma drug

Results mean patients could switch to once-daily inhaler use

FDA rejects Sunovion's nebulised COPD drug

European regulators back Chiesi COPD triple therapy

GSK’s Relvar Ellipta comes out on top in real world study

Circassia gives up on allergy treatments after second trial ...

AZ strikes COPD deal with Circassia, suffers setback with bl...

Good news for GSK’s next generation asthma drug

Lilly bags FDA okay for Wegovy pill rival orforglipron

Using AI-driven synthetic personas to take your insights fur...

COPD

Editor's Picks